NAT10 and pancreatic ductal adenocarcinoma: That pathway correlation analysis revealed that NAT10 was positively correlated with PI3K-AKT activation and cell proliferation characteristics, suggesting that abnormal expression of NAT10 may promote the malignant proliferation of pancreatic ductal adenocarcinoma through activation of the PI3K-AKT pathway.